Chong Kun Dang Pharmaceutical: Cardiovascular Diseases trials
The registry lists 11 Cardiovascular Diseases studies with Chong Kun Dang Pharmaceutical as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 10Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting ConditionsStatus unknownNCT04906798Phase 1
- Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed ConditionsStatus unknownNCT04906785Phase 1
- Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting ConditionsStatus unknownNCT04678388Phase 1
- Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed ConditionsStatus unknownNCT04651881Phase 1
- A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy VolunteersStatus unknownNCT04627207Phase 1
- Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy VolunteersStatus unknownNCT04611932Phase 1
- Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy VolunteersStatus unknownNCT04478097Phase 1
- Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)CompletedNCT04083872Phase 1
- Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)CompletedNCT04083846Phase 1
- Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy VolunteersCompletedNCT04075643Phase 1
- Dyslipidemia in Cardiovascular DiseaseCompletedNCT01029522Phase 4